Cell cycle plasticity underlies fractional resistance to palbociclib in ER+/HER2- breast tumor cells
T. M. Zikry, S. C. Wolff, J. S. Ranek, H. Davis, A. Naugle, A. A. Whitman, M. R. Kosorok, P. M. Spanheimer, J. E. Purvis
This study identifies cell cycle plasticity as a mechanism for fractional resistance to palbociclib in ER+/HER2- breast tumor cells using single-cell imaging and computational analysis.
bioRxiv · May 22, 2023Cancer Biology